Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer

Cancer Letters

Volumn 119, Issue 2, 1997, Pages 227-235

  Amaya, H ^a   Tanigawa, N ^b   Lu, C ^b   Matsumura, M ^a   Shimomatsuya, T ^a   Horiuchi, T ^a   Muraoka, R ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Colorectal cancer; Prognosis; Thymidine phosphorylase platelet derived endothelial cell growth factor (dThdPase PD ECGF); Tumor angiogenesis; Vascular endothelial growth factor (VEGF)

Indexed keywords

CD34 ANTIGEN; GROWTH FACTOR RECEPTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL ANALYSIS; THYMIDINE PHOSPHORYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030700901     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00280-2     Document Type: Article

References (52)

1. J. Folkman, Y. Shing, Angiogenesis, J. Biol. Chem. 267 (1992) 10931-10934.
2. A. Srivastava, P. Laidler, L.E. Hughes, J. Woodcock, E.J. Shedden, Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study, Eur. J. Cancer Clin. Oncol. 22 (1986) 1205-1209.
3. N. Weidner, J.P. Semple, W.R. Welch, J. Folkman, Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma, N. Engl. J. Med. 324 (1991) 1-8.
4. G. Fontanini, D. Bigini, S. Vignati, F. Basolo, A. Mussi, M. Lucchi, S. Chine, C.A. Angeletti, A.L. Harris, G. Bevilacqua, Microvessel count predicts metastatic disease and survival in non-small cell lung cancer, J. Pathol. 177 (1995) 57-63.
5. N. Tanigawa, H. Amaya, M. Matsumura, T. Shimomatsuya, T. Horiuchi, R. Muraoka, M. Iki, Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas, Cancer Res. 56 (1996) 2671-2676.
6. H.F. Dvorak, N.S. Orenstein, A.C. Carvalho, W.H. Churchill, A.M. Dvorak, S.J. Galli, J. Feder, A.M. Bitzer, J. Rypysc, P. Giovinco, Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor secreted products, J. Immunol. 122 (1979) 166-174.
7. H. Ohtani, S. Nakamura, Y. Watanabe, T. Mizoi, T. Saku, H. Nagura, Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract, Lab. Invest. 68 (1993) 520-527.
8. T. Furukawa, A. Yoshimura, T. Sumizawa, M. Haraguchi, S. Akiyama, K. Fukui, M. Ishizawa, Y. Yamada, Angiogenic factor, Nature 356 (1992) 668.
9. D.S. Grant, H.K. Kleinman, I.D. Goldberg, M.M. Bhargava, B.J. Nickoloff, J.L. Kinsella, P. Polverini, E.M. Rosen, Scatter factor induces blood vessel formation in vivo, Proc. Natl. Acad. Sci. USA 90 (1993) 1937-1941.
10. L.T. Malden, U. Novak, A.W. Burgess, Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastrointestinal tract, Int. J. Cancer 43 (1989) 380-384.
11. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses, W.S. Lane, Y. Cao, E.H. Sage, J. Folkman, Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma, Cell 79 (1994) 315-328.
12. R.K. Singh, C.D. Bucana, M. Gutman, D. Fan, M.R. Wilson, I.J. Fidler, Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells, Am. J. Pathol. 145 (1994) 365-374.
13. K.M. Dameron, O.V. Volpert, M.A. Tainsky, N. Bouck, Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1, Science 265 (1994) 1582-1584.
14. J. Folkman, Angiogenesis: initiation and modulation, Symp. Fundam. Cancer Res. 36 (1983) 201-208.
15. L.F. Brown, B. Berse, K. Tognazzi, E.J. Manseau, L. Van de Water, D.R. Senger, H.F. Dvorak, S. Rosen, Vascular permeability factor mRNA and protein expression in human kidney, Kidney Int. 42 (1992) 1457-1461.
16. L.F. Brown, B. Berse, R.W. Jackman, K. Tognazzi, E.J. Manseau, H.F. Dvorak, D.R. Senger, Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas, Am. J. Pathol. 143 (1993) 1255-1262.
17. K.J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H.S. Phillips, N. Ferrara, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature 362 (1993) 841-844.
18. R.S. Warren, H. Yuan, M.R. Matli, N.A. Gillett, N. Ferrara, Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis, J. Clin. Invest. 95 (1995) 1789-1797.
19. N. Tanigawa, H. Amaya, M. Matsumura, T. Shimomatsuya, Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma, J. Clin. Oncol. 15 (1997) 826-832.
20. N. Tanigawa, H. Amaya, M. Matsumura, C. Lu, A. Kitaoka, K. Matsuyama, R. Muraoka, Tumor angiogenesis and mode of metastasis in patients with colorectal cancer, Cancer Res. 57 (1997) 1043-1046.
21. N. Tanigawa, H. Amaya, M. Matsumura, Y. Katoh, A. Kitaoka, T. Aotake, T. Shimomatsuya, O.A. Rosenwasser, M. Iki, Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma, Cancer Lett. 108 (1996) 281-290.
22. M. Toi, S. Hoshina, T. Taniguchi, Y. Yamamoto, H. Ishitsuka, T. Tominaga, Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer, Int. J. Cancer 64 (1995) 79-82.
23. Y. Takebayashi, S. Akiyama, S. Akiba, K. Yamada, K. Miyadera, T. Sumizawa, Y. Yamada, F. Murata, T. Aikou, Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma, J. Natl. Cancer Inst. 88 (1996) 1110-1117.
24. Y. Takahashi, C.D. Bucana, W. Liu, J. Yoneda, Y. Kitadai, K.R. Cleary, L.M. Ellis, Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells, J. Natl. Cancer Inst. 88 (1996) 1146-1151.
25. Japanese Research Society for Cancer of the Colon and Rectum, General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, fifth ed., Kanehara Co., Tokyo, 1994.
26. H. Goulding, N.F. Abdul-Rashid, J.F. Robertson, J.A. Bell, C.W. Elston, R.W. Blamey, I.O. Ellis, Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum. Pathol. 26 (1995) 1196-1200.
27. S.M. Siitonen, H.K. Haapasalo, I.S. Rantala, H.J. Helin, J.J. Isola, Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas, Mod. Pathol. 8 (1995) 745-752.
28. H.F. Dvorak, L.F. Brown, M. Detmar, A.M. Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am. J. Pathol. 146 (1995) 1029-1039.
29. E. Tischer, R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J.C. Fiddes, J.A. Abraham, The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing, J. Biol. Chem. 266 (1991) 947-11954.
30. J.E. Park, G.A. Keller, N. Ferrara, The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF, Mol. Biol. Cell 4 (1993) 1317-1326.
31. D.R. Senger, L. Van de Water, L.F. Brown, J.A. Nagy, K.T. Yeo, T.K. Yeo, B. Berse, R.W. Jackman, A.M. Dvorak, H.F. Dvorak, Vascular permeability factor (VPF, VEGF) in tumor biology, Cancer Metastasis Rev. 12 (1993) 303-324.
32. W.G. Roberts, G.E. Palade, Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor, J. Cell Sci. 108 (1995) 2369-2379.
33. H.T. Zhang, P. Craft, P.A. Scott, M. Ziehe, H.A. Weich, A.L. Harris, R. Bicknell, Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 human breast carcinoma cells, J. Natl. Cancer Inst. 87 (1995) 213-219.
34. A.J. Potgens, M.C. van Altena, N.H. Lubsen, D.J. Ruiter, R.M. de Waal, Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor, Am. J. Pathol. 148 (1996) 1203-1217.
35. R.A. Berkman, M.J. Merrill, W.C. Reinhold, W.T. Monacci, A. Saxena, W.C. Clark, J.T. Robertson, I.U. Ali, E.H. Oldfield, Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms, J. Clin. Invest. 91 (1993) 153-159.
36. K. Samoto, K. Ikezaki, M. Ono, T. Shono, K. Kohno, M. Kuwano, M. Fukui, Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors, Cancer Res. 55 (1995) 1189-1193.
37. M. Toi, S. Hoshina, T. Takayanagi, T. Tominaga, Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer, Jpn. J. Cancer Res. 85 (1994) 1045-1049.
38. L.R. Brown, B. Berse, R.W. Jackman, K. Tognazzi, A.J. Guidi, H.F. Dvorak, D.R. Senger, J.L. Connolly, S.J. Schnitt, Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer, Hum. Pathol. 26 (1995) 86-91.
39. G. Gasparini, M. Toi, M. Gion, P. Verderio, R. Dittadi, M. Hanatani, I. Matsubara, O. Vinante, E. Bonoldi, P. Boracchi, C. Gatti, H. Suzuki, T. Tominaga, Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma, J. Natl. Cancer Inst. 89 (1997) 139-147.
40. Y. Takahashi, K.R. Cleary, M. Mai, Y. Kitadai, C.D. Bucana, L.M. Ellis, Significance of vessel count and its receptor (KDR) in intestinal-type gastric cancer, Clin. Cancer Res. 2 (1996) 1679-1684.
41. K. Maeda, Y. Chung, Y. Ogawa, S. Takatsuka, S. Kang, M. Ogawa, T. Sawada, M. Sowa, Prognostic value of vascular endothelial growth factor expression in gastric carcinoma, Cancer 77 (1996) 858-863.
42. Y. Takahashi, Y. Kitadai, C.D. Bucana, K.R. Cleary, L.M. Ellis, Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer, Cancer Res. 55 (1995) 3964-3968.
43. L.F. Brown, B. Berse, R.W. Jackman, K. Tognazzi, E.J. Manseau, D.R. Senger, H.F. Dvorak, Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract, Cancer Res. 53 (1993) 4727-4735.
44. C.A. Boocock, D.S. Charnock-Jones, A.M. Sharkey, J. McLaren, P.J. Barker, K.A. Wright, P.R. Twentyman, S.K. Smith, Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma, J. Natl. Cancer Inst. 87 (1995) 506-516.
45. B.I. Terman, M. Dougher Vermazen, M.E. Carrion, D. Dimitrov, D.C. Armellino, D. Gospodarowics, P. Bohlen, Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor, Biochem. Biophys. Res. Commun. 187 (1992) 1579-1586.
46. C. de-Vries, J.A. Escobedo, H. Ueno, K. Houck, N. Ferrara, L.T. Williams, The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255 (1992) 989-991.
47. A. Moghaddam, R. Bicknell, Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity, Biochemistry 31 (1992) 12141-12146.
48. F. Ishikawa, K. Miyazono, U. Hellman, H. Drexler, C. Wernstedt, K. Hagiwara, K. Usuki, F. Takaki, W.W. Risau, C.H. Heldin, Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor, Nature 338 (1989) 557-562.
49. K. Miyadera, T. Sumizawa, M. Haraguchi, H. Yoshida, W. Konstanty, Y. Yamada, S. Akiyama, Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phos-phorylase, Cancer Res. 55 (1995) 1687-1690.
50. M. Detmar, K.T. Yeo, J.A. Nagy, L. Van de Water, L.F. Brown, B. Berse, B.M. Elicker, S. Ledbetter, H.F. Dvorak, Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells, J. Invest. Dermatol. 105 (1995) 44-50.
51. H. Eda, K. Fujimoto, S. Watanabe, M. Ura, A. Hino, Y. Tanaka, K. Wada, H. Ishitsuka, Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine, Cancer Chemother. Pharmacol. 32 (1993) 333-338.
52. M. Toi, K. Inada, H. Hoshina, H. Suzuki, S. Kondo, T. Tominaga, Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer, Clin. Cancer Res. 1 (1995) 961-964.